Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Long CAG repeat sequence and protein expression of androgen receptor considered as prognostic indicators in male breast carcinoma.

Song YN, Geng JS, Liu T, Zhong ZB, Liu Y, Xia BS, Ji HF, Li XM, Zhang GQ, Ren YL, Li ZG, Pang D.

PLoS One. 2012;7(12):e52271. doi: 10.1371/journal.pone.0052271. Epub 2012 Dec 14.

2.

Polymorphic CAG Repeat and Protein Expression of Androgen Receptor Gene in Colorectal Cancer.

Huang R, Wang G, Song Y, Wang F, Zhu B, Tang Q, Liu Z, Chen Y, Zhang Q, Muhammad S, Wang X.

Mol Cancer Ther. 2015 Apr;14(4):1066-74. doi: 10.1158/1535-7163.MCT-14-0620. Epub 2015 Jan 30.

3.

Increased frequency of long androgen receptor CAG repeats in male breast cancers.

MacLean HE, Brown RW, Beilin J, Warne GL, Zajac JD.

Breast Cancer Res Treat. 2004 Dec;88(3):239-46.

PMID:
15609126
4.

BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.

Kwiatkowska E, Teresiak M, Filas V, Karczewska A, Breborowicz D, Mackiewicz A.

Clin Cancer Res. 2003 Oct 1;9(12):4452-9.

5.

Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer.

Yu H, Bharaj B, Vassilikos EJ, Giai M, Diamandis EP.

Breast Cancer Res Treat. 2000 Jan;59(2):153-61.

PMID:
10817350
6.

Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.

Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen YL, Stanczyk FZ, Chang C.

Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):337-41.

7.

Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer.

Rosa FE, dos Santos RM, Poli-Frederico RC, Canevari Rde A, Nishimoto IN, Magrin J, Rainho CA, Kowalski LP, Rogatto SR.

Arch Oral Biol. 2007 Aug;52(8):732-9. Epub 2007 Feb 23.

PMID:
17321486
8.

The androgen receptor CAG repeat: a modifier of carcinogenesis?

Ferro P, Catalano MG, Dell'Eva R, Fortunati N, Pfeffer U.

Mol Cell Endocrinol. 2002 Jul 31;193(1-2):109-20. Review.

PMID:
12161010
9.

Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.

Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C.

Cancer Res. 2000 Sep 15;60(18):5111-6.

10.
11.

CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.

Kim SC, Ju W, Mahavni V, Geisler JP, Buller RE.

Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:190-4. Erratum in: Int J Gynecol Cancer. 2006 May-Jun;16(3):1489.

PMID:
16515589
12.

South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.

Krishnaswamy V, Kumarasamy T, Venkatesan V, Shroff S, Jayanth VR, Paul SF.

J Hum Genet. 2006;51(3):254-7. Epub 2006 Jan 26.

PMID:
16437189
13.

The androgen receptor gene GGN microsatellite and prostate cancer risk.

Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW.

Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):379-84.

14.

Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men.

Di Fabio F, Alvarado C, Gologan A, Youssef E, Voda L, Mitmaker E, Beitel LK, Gordon PH, Trifiro M.

J Surg Res. 2009 Jun 1;154(1):38-44. doi: 10.1016/j.jss.2008.05.013. Epub 2008 Jun 11.

PMID:
19062046
15.

The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

Haiman CA, Brown M, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW, Hunter DJ.

Cancer Res. 2002 Feb 15;62(4):1045-9.

16.

Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA.

Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):127-35.

17.
18.

Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients.

Gilbert SF, Soliman AS, Karkouri M, Quinlan-Davidson M, Strahley A, Eissa M, Dey S, Hablas A, Seifeldin IA, Ramadan M, Benjaafar N, Toy K, Merajver SD.

Breast Dis. 2011;33(1):17-26. doi: 10.3233/BD-2010-0323.

19.

Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?

Mishra D, Thangaraj K, Mandhani A, Kumar A, Mittal R.

Clin Genet. 2005 Jul;68(1):55-60.

PMID:
15952987
20.

Shorter CAG repeat in the AR gene is associated with atypical hyperplasia and breast carcinoma.

De Abreu FB, Pirolo LJ, Canevari Rde A, Rosa FE, Moraes Neto FA, Caldeira JR, Rainho CA, Rogatto SR.

Anticancer Res. 2007 Mar-Apr;27(2):1199-205.

Supplemental Content

Support Center